Piperidine ureas as cathepsin cysteine protease inhibitors
WO2016027285A2
Bicyclic heteroaryl amides as cathepsin cysteine protease inhibitors
WO2014106865A1
Abuse-proofed, extended release pharmaceutical composition comprising tapentadol or a pharmaceutically acceptable salt thereof and processes for preparing thereof
WO2013072934A1
A novel process for the optical purification of proton pump inhibitors and pharmaceutically acceptable salts thereof.
US2014316142A1
Process for the preparation of angiotensin ii antagonists and intermediates thereof
